Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2021.42531
Abstract: Because it constrains telemedicine use for opioid use disorder (OUD), many have advocated for the repeal of the Ryan Haight Act requirement that clinicians conduct an in-person evaluation before prescribing buprenorphine.1,2 The SUPPORT Act of… read more here.
Keywords: telemedicine buprenorphine; patients commercial; use telemedicine; buprenorphine inductions ... See more keywords